Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

Investor Overview

Investor Overview

Corporate Profile

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

News Releases

Date Title and Summary Additional Formats
Toggle Summary Charles River Laboratories Demonstrates Industry-Leading Research at Neuroscience 2019
WILMINGTON, Mass. --(BUSINESS WIRE)--Oct. 16, 2019-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that its team of neuroscience drug discovery experts will present 37 scientific posters, both independently and collaboratively with clients, at Neuroscience 2019, the
View HTML
Toggle Summary Charles River Laboratories Joins Dementia Consortium, Reaffirms Commitment to Neuroscience Research
  WILMINGTON, Mass. --(BUSINESS WIRE)--Oct. 3, 2019-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that the Company has been selected by Alzheimer’s Research UK to join the Dementia Consortium . The Consortium is a global charity-industry partnership aimed at funding
View HTML
Toggle Summary Charles River Laboratories Adds Virginia M. Wilson to Board of Directors
  WILMINGTON, Mass. --(BUSINESS WIRE)--Oct. 1, 2019-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of Virginia M. (Gina) Wilson , the recently retired Senior Executive Vice President and Chief Financial Officer of Teachers Insurance and Annuity
View HTML
Toggle Summary Charles River Laboratories Announces Updates to Microbial Solutions Product Portfolio
New EndoScan-V™ endotoxin detection software and Celsis ® automated detection platform for rapid sterility introduced to address unmet industry needs WILMINGTON, Mass. --(BUSINESS WIRE)--Sep. 9, 2019-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of two new
View HTML
Upcoming Events
There are currently no events scheduled.

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)